Showing results (1-10 of 179) with videos related to
Sort By:
Pageof 18
Current Opinion in Immunology|April 10, 2018
Vaccine options for influenza: thinking smallBert Schepens, Dorien De Vlieger, Xavier SaelensAntibodies (Basel, Switzerland)|September 24, 2019
Single-Domain Antibodies and Their Formatting to Combat Viral InfectionsDorien De Vlieger, Marlies Ballegeer, Iebe Rossey, et al.Journal of Visualized Experiments : Jove|May 5, 2015
Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus NucleoproteinJudith Verhelst, Dorien De Vlieger, Xavier SaelensPlos Pathogens|October 18, 2019
Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responsesKoen Sedeyn, Bert Schepens, Xavier SaelensMolecular Therapy. Nucleic Acids|May 22, 2020
mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in MiceLien Van Hoecke, Rein Verbeke, Dorien De Vlieger, et al.Frontiers in Immunology|January 11, 2020
Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus InfectionDorien De Vlieger, Katja Hoffmann, Inge Van Molle, et al.Expert Review of Vaccines|September 23, 2016
M2-based influenza vaccines: recent advances and clinical potentialAnnasaheb Kolpe, Bert Schepens, Walter Fiers, et al.Trends in Microbiology|October 22, 2017
Clinical Potential of Prefusion RSV F-specific AntibodiesIebe Rossey, Jason S McLellan, Xavier Saelens, et al.Expert Review of Vaccines|February 19, 2013
Hepatitis B core-based virus-like particles to present heterologous epitopesKenny Roose, Sarah De Baets, Bert Schepens, et al.The Journal of Biological Chemistry|December 25, 2016
Chemical-controlled Activation of Antiviral Myxovirus Resistance Protein 1Judith Verhelst, Lien Van Hoecke, Jan Spitaels, et al.Pageof 18